US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
ES2127458T3
(es)
*
|
1989-11-06 |
1999-04-16 |
Cell Genesys Inc |
Produccion de proteinas utilizando recombinacion homologa.
|
US5272071A
(en)
*
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
EP0505500B1
(de)
*
|
1989-12-22 |
1997-07-30 |
Applied Research Systems Ars Holding N.V. |
Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination
|
GB9028062D0
(en)
*
|
1990-12-24 |
1991-02-13 |
Agricultural & Food Res |
Production of transgenic animals
|
ATE272121T1
(de)
*
|
1991-05-06 |
2004-08-15 |
Cell Genesys Inc |
Gene manipulation und expression mittels genomischer elemente
|
WO1992021763A1
(en)
*
|
1991-05-31 |
1992-12-10 |
Genentech, Inc. |
Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
|
AU2515992A
(en)
*
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
NZ245015A
(en)
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US5733761A
(en)
*
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US5641670A
(en)
*
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6270989B1
(en)
*
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US20020108136A1
(en)
*
|
1997-03-21 |
2002-08-08 |
Sri |
Transgenic animals produced by homologous sequence targeting
|
AU4401993A
(en)
*
|
1992-06-04 |
1993-12-30 |
Exemplar Corporation |
Insertion of heterologous dna outside of known chromosomal genes
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US5733753A
(en)
*
|
1992-12-22 |
1998-03-31 |
Novo Nordisk A/S |
Amplification of genomic DNA by site specific integration of a selectable marker construct
|
JP4375759B2
(ja)
|
1993-04-21 |
2009-12-02 |
ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラ |
標的とされた発現特性に従う異種遺伝子の発現
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US5798448A
(en)
|
1994-10-27 |
1998-08-25 |
Genentech, Inc. |
AL-1 neurotrophic factor antibodies
|
US6610296B2
(en)
|
1995-10-26 |
2003-08-26 |
Genentech, Inc. |
Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
|
WO1997025425A1
(en)
|
1996-01-08 |
1997-07-17 |
Genentech, Inc. |
Wsx receptor and ligands
|
US7063958B1
(en)
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US7084252B1
(en)
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7148004B1
(en)
|
1997-01-16 |
2006-12-12 |
The Rockefeller University |
Oligonucleotides of the OB-R isoforms and methods of diagnosing body weight
|
US7619079B2
(en)
|
1996-02-14 |
2009-11-17 |
The Rockefeller University |
Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
|
US5792210A
(en)
*
|
1996-06-10 |
1998-08-11 |
Environmental Behavior Modification Inc. |
Electrical tongue stimulator and method for addiction treatment
|
JP2000517185A
(ja)
|
1996-08-29 |
2000-12-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
新規なメタロプロテアーゼファミリーkuz
|
US6566089B1
(en)
|
1996-09-04 |
2003-05-20 |
Tularik Inc. |
Cell-based drug screens for regulators of gene expression
|
JP4436934B2
(ja)
*
|
1996-09-13 |
2010-03-24 |
ノボザイムス,インコーポレイティド |
変更された量のポリペプチドを生成するdna挿入突然変異を有する細胞
|
JPH10117771A
(ja)
*
|
1996-10-23 |
1998-05-12 |
Natl Food Res Inst |
冷凍生地耐性実用パン酵母
|
US5925544A
(en)
*
|
1996-11-18 |
1999-07-20 |
Novo Nordisk A/S |
Method of homologous recombination followed by in vivo selection of DNA amplification
|
US6326204B1
(en)
*
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
IL130635A0
(en)
|
1997-01-17 |
2000-06-01 |
Maxygen Inc |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
*
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6025157A
(en)
*
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
US6372453B1
(en)
|
1997-02-18 |
2002-04-16 |
Genetech, Inc. |
Neurturin receptor
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
DE69830312T2
(de)
|
1997-03-14 |
2006-02-02 |
Biogen Idec Inc., San Diego |
Methode zur spezifischen integration von genen in säugetierzellen durch homologe rekombination, und vektoren zu deren durchführung
|
US5948653A
(en)
*
|
1997-03-21 |
1999-09-07 |
Pati; Sushma |
Sequence alterations using homologous recombination
|
US6172211B1
(en)
|
1997-07-11 |
2001-01-09 |
Boehringer Ingelheim International Gmbh |
Nucleic acid encoding tag7 polypeptide
|
WO1999005268A1
(de)
*
|
1997-07-23 |
1999-02-04 |
Roche Diagnostics Gmbh |
Herstellung von erythropoietin durch endogene genaktivierung
|
US6548296B1
(en)
|
1997-07-23 |
2003-04-15 |
Roche Diagnostics Gmbh |
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
|
DK1000154T3
(da)
*
|
1997-07-23 |
2007-06-18 |
Roche Diagnostics Gmbh |
Identificering af humane cellelinjer til produktion af humane proteiner ved endogen genaktivering
|
KR100641969B1
(ko)
|
1997-07-23 |
2006-11-06 |
로셰 디아그노스틱스 게엠베하 |
내인성 유전자 활성화에 의한 에리트로포이에틴의제조방법
|
KR100622203B1
(ko)
|
1997-07-23 |
2006-09-07 |
로셰 디아그노스틱스 게엠베하 |
내인성 유전자 활성화에 의해 사람 단백질을 생성시키는 사람 세포주를 확인하는 방법
|
WO1999015650A1
(en)
|
1997-09-26 |
1999-04-01 |
Athersys, Inc. |
Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
|
US6740503B1
(en)
|
1997-09-26 |
2004-05-25 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
US6897066B1
(en)
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
ZA989497B
(en)
†
|
1997-10-20 |
2000-04-19 |
Roche Diagnostics Gmbh |
Positive-negative selection in homologous recombination.
|
KR100760221B1
(ko)
|
1997-11-28 |
2007-10-30 |
세로노 제네틱스 인스티튜트 에스.에이. |
클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
|
AU757930B2
(en)
*
|
1997-12-01 |
2003-03-13 |
Roche Diagnostics Gmbh |
Optimization of cells for endogenous gene activation
|
JPH11243944A
(ja)
*
|
1998-03-04 |
1999-09-14 |
Natl Food Res Inst |
製パン用乾燥耐性実用パン酵母
|
US6426191B1
(en)
|
1998-04-03 |
2002-07-30 |
Hyseq, Inc. |
Assays involving an IL-1 receptor antagonist
|
US6541623B1
(en)
|
1998-04-03 |
2003-04-01 |
Hyseq, Inc. |
Interleukin—1 receptor antagonist and uses thereof
|
US6294655B1
(en)
|
1998-04-03 |
2001-09-25 |
Hyseq, Inc. |
Anti-interleukin-1 receptor antagonist antibodies and uses thereof
|
US6337072B1
(en)
|
1998-04-03 |
2002-01-08 |
Hyseq, Inc. |
Interleukin-1 receptor antagonist and recombinant production thereof
|
EP2348118A1
(de)
|
1998-07-21 |
2011-07-27 |
Millipore Corporation |
Ein allgegenwärtiges chromatin-öffnendes Element (ucoe) enthaltendes Polynucleotid
|
EP1123401A1
(de)
*
|
1998-10-22 |
2001-08-16 |
The General Hospital Corporation |
Bioaktive peptide und peptid-derivate von parathyroidhormon (pth) und parathyroidhormon verwandte peptide (pthrp)
|
US6773911B1
(en)
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
TW570977B
(en)
*
|
1998-12-07 |
2004-01-11 |
Li-Wei Hsu |
An expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
DE69940364D1
(de)
|
1999-05-18 |
2009-03-19 |
Dyax Corp |
Fab Fragmentbibliotheken und Verfahren für deren Verwendung
|
US6495360B1
(en)
*
|
1999-05-28 |
2002-12-17 |
Photogen, Inc. |
Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
|
US20050129669A1
(en)
*
|
1999-06-21 |
2005-06-16 |
Transkaryotic Therapies, Inc., A Massachusetts Corporation |
DNA construct for effecting homologous recombination and uses thereof
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
WO2001023521A2
(en)
*
|
1999-09-29 |
2001-04-05 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (pth)
|
ES2316354T3
(es)
|
1999-09-29 |
2009-04-16 |
The General Hospital Corporation |
Derivados polipeptidos de la hormona paratiroidea (pth).
|
WO2001042442A2
(en)
|
1999-12-10 |
2001-06-14 |
Cytos Biotechnology Ag |
Activation of endogenous genes by genomic introduction of a replicon
|
AU2001234443A1
(en)
*
|
2000-01-13 |
2001-07-24 |
Novozymes Biotech, Inc. |
Methods for producing a polypeptide using a crippled translational initiator sequence
|
EP1254230A2
(de)
|
2000-02-29 |
2002-11-06 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g-protein-gekoppelte rezeptoren und deren anwendungen
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US6656700B2
(en)
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
US6686188B2
(en)
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
GB0018876D0
(en)
|
2000-08-01 |
2000-09-20 |
Applied Research Systems |
Method of producing polypeptides
|
MXPA03001915A
(es)
*
|
2000-08-03 |
2004-09-10 |
Therapeutic Human Polyclonals |
Produccion de anticuerpos humanizados en animales transgenicos.
|
EP1191036A3
(de)
|
2000-08-25 |
2002-07-03 |
Pfizer Products Inc. |
Methoden und Verbindungen zur Diagnose und Behandlung von Krankheiten, an denen Angiogenese beteiligt ist
|
AU2002220209B2
(en)
|
2000-12-06 |
2006-05-25 |
Robert J. Hariri |
Method of collecting placental stem cells
|
US20030032179A1
(en)
|
2000-12-06 |
2003-02-13 |
Hariri Robert J. |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
KR100645843B1
(ko)
*
|
2000-12-20 |
2006-11-14 |
에프. 호프만-라 로슈 아게 |
에리트로포이에틴 접합체
|
ATE505204T1
(de)
|
2000-12-20 |
2011-04-15 |
Hoffmann La Roche |
Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
KR101012952B1
(ko)
|
2001-02-14 |
2011-02-08 |
안트로제네시스 코포레이션 |
산후 포유류의 태반, 이의 용도 및 태반 줄기세포
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
ES2312620T3
(es)
|
2001-06-06 |
2009-03-01 |
BIORIGINAL FOOD & SCIENCE CORP. |
Secuencias especificas de la semilla de lino (linum usitatissiumum l.).
|
EP1925671A1
(de)
|
2001-06-06 |
2008-05-28 |
Bioriginal Food & Science Corp. |
Flax-(Linum usitatissimum L.)-Samenspezifische Promotoren
|
CA2454275C
(en)
*
|
2001-07-23 |
2012-10-23 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
CA2459161A1
(en)
|
2001-08-31 |
2003-03-13 |
The Rockefeller University |
Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
EP1455815A4
(de)
|
2001-12-19 |
2006-11-02 |
Millennium Pharm Inc |
Mitglieder der familie der humanen diacylglycerol-acyltransferase 2 (dgat2) und ihre verwendung
|
EP1468099A2
(de)
*
|
2002-01-17 |
2004-10-20 |
Lonza Biologics plc |
Zur produktion von proteinen und zum wachstum in einem glutaminfreien medium fähige glutaminauxotrophe menschliche zellen
|
EP2186407A1
(de)
|
2002-02-13 |
2010-05-19 |
Anthrogenesis Corporation |
Embryoartige Stammzellen aus der Post Partum Plazenta von Säugetieren sowie Anwendungszwecke und Behandlungsverfahren, bei denen diese Zellen verwendet werden
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
US20060052320A1
(en)
*
|
2002-05-06 |
2006-03-09 |
Limin Li |
Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
|
AU2003239589A1
(en)
|
2002-05-24 |
2003-12-12 |
Schering-Plough Ltd. |
Eta-1 gene and methods for use
|
AU2003265525A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
|
AU2003268135A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
AU2003293013A1
(en)
|
2002-11-21 |
2004-06-18 |
University Of Massachusets |
Diagnosing and treating hematopoietic cancers
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
KR101042448B1
(ko)
|
2002-11-26 |
2011-06-16 |
안트로제네시스 코포레이션 |
세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
WO2004063356A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Rao Mahendra S |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
JP5568208B2
(ja)
|
2003-01-14 |
2014-08-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
癌治療感作物質
|
US8021833B2
(en)
|
2003-02-12 |
2011-09-20 |
Functional Genetics, Inc. |
Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
|
US7795220B2
(en)
*
|
2003-03-19 |
2010-09-14 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormones with alpha-helix stabilizers
|
US7910544B2
(en)
|
2003-07-17 |
2011-03-22 |
The General Hospital Corporation |
Conformationally constrained parthyroid hormone (PTH) analogs
|
US7287952B2
(en)
*
|
2003-07-23 |
2007-10-30 |
Lockheed Martin Corporation |
Feeder load automation system and method of use
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
ZA200603396B
(en)
|
2003-09-29 |
2007-11-28 |
Warren Pharmaceuticals Inc |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
EP1694706B1
(de)
|
2003-11-01 |
2012-04-04 |
Merck Patent GmbH |
Modifizierter anti-cd52-antikörper
|
WO2005058347A1
(en)
*
|
2003-12-19 |
2005-06-30 |
F. Hoffmann-La Roche Ag |
Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases
|
DK1709161T3
(da)
*
|
2004-01-19 |
2009-01-26 |
Nsgene As |
Humane terapeutiske celler, som udskiller nervevækstfaktor
|
WO2006017621A2
(en)
|
2004-08-02 |
2006-02-16 |
Janssen Pharmaceutica N.V. |
IRAK1c SPLICE VARIANT AND ITS USE
|
US7893197B2
(en)
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
US7893034B2
(en)
|
2004-09-02 |
2011-02-22 |
Yale University |
Regulation of oncogenes by microRNAs
|
AU2005299413A1
(en)
|
2004-10-22 |
2006-05-04 |
Revivicor, Inc. |
Ungulates with genetically modified immune systems
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
EP1844068A4
(de)
*
|
2005-01-25 |
2009-09-30 |
Apollo Life Sciences Ltd |
Moleküle und chimere moleküle davon
|
WO2006084352A1
(en)
|
2005-02-09 |
2006-08-17 |
Bioriginal Food & Science Corp. |
Novel omega-3 fatty acid desaturase family members and uses thereof
|
WO2006121560A2
(en)
|
2005-04-06 |
2006-11-16 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for treatment of cns disorders
|
US8354384B2
(en)
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
ES2452595T3
(es)
|
2005-10-13 |
2014-04-02 |
Anthrogenesis Corporation |
Inmunomodulación usando células madre de la placenta
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
US8014957B2
(en)
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
KR20210122908A
(ko)
|
2005-12-29 |
2021-10-12 |
안트로제네시스 코포레이션 |
태반 줄기 세포 집단
|
AU2006332679A1
(en)
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
LT2004683T
(lt)
|
2006-03-24 |
2016-10-10 |
Biogen Hemophilia Inc. |
Pc5, kaip faktoriaus ix pro-peptidą apdorojantis fermentas
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
CA2659990C
(en)
|
2006-08-04 |
2016-03-22 |
Prolong Pharmaceuticals, Inc. |
Polyethylene glycol erythropoietin conjugates
|
WO2008019062A2
(en)
*
|
2006-08-04 |
2008-02-14 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (pth)
|
PE20081216A1
(es)
|
2006-09-01 |
2008-09-04 |
Therapeutic Human Polyclonals Inc |
Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
|
DK2084268T3
(en)
|
2006-10-23 |
2019-01-21 |
Celularity Inc |
METHODS AND COMPOSITIONS FOR TREATING BONE JOIN DEFECTS WITH PLACENTACLE POPULATIONS
|
CA2667196A1
(en)
*
|
2006-10-30 |
2008-11-06 |
Functional Genetics, Inc. |
Random homozygous gene perturbation to enhance antibody production
|
DK2120977T3
(da)
|
2007-02-12 |
2013-08-12 |
Anthrogenesis Corp |
Behandling af inflammatoriske sygdomme under anvendelse af placenta-stamceller
|
CA2679954A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
KR101461659B1
(ko)
|
2007-05-11 |
2014-11-17 |
토마스 제퍼슨 유니버시티 |
신경변성 질환 및 장애의 치료 및 예방 방법
|
EA018101B1
(ru)
|
2007-05-11 |
2013-05-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Способы лечения кожных язв
|
WO2008157776A2
(en)
|
2007-06-21 |
2008-12-24 |
Angelica Therapeutics, Inc. |
Modified diphtheria toxins
|
AR067537A1
(es)
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Purificacion de polipeptidos pegilados
|
CL2008002054A1
(es)
|
2007-07-17 |
2009-05-29 |
Hoffmann La Roche |
Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
BRPI0814962B8
(pt)
|
2007-08-01 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
AU2008304615A1
(en)
|
2007-09-24 |
2009-04-02 |
Cornell University |
Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon
|
KR20210022148A
(ko)
|
2007-09-28 |
2021-03-02 |
안트로제네시스 코포레이션 |
인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
|
US8501449B2
(en)
|
2007-12-04 |
2013-08-06 |
Proteon Therapeutics, Inc. |
Recombinant elastase proteins and methods of manufacturing and use thereof
|
EP2570501A3
(de)
|
2008-01-02 |
2013-04-10 |
Suregene Llc |
Genetische Marker für Geisteskrankheiten
|
AU2009205920A1
(en)
|
2008-01-17 |
2009-07-23 |
Suregene Llc |
Genetic markers of mental illness
|
WO2009111375A2
(en)
*
|
2008-03-01 |
2009-09-11 |
Abraxis Bioscience, Llc |
Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
|
US20110071049A1
(en)
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
CN102076853A
(zh)
*
|
2008-05-07 |
2011-05-25 |
阿布拉西斯生物科学有限责任公司 |
通过miRNA增强药物疗法
|
KR20110050521A
(ko)
|
2008-08-20 |
2011-05-13 |
안트로제네시스 코포레이션 |
개선된 세포 조성물 및 그의 제조 방법
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2631303A1
(de)
|
2008-09-25 |
2013-08-28 |
SureGene LLC |
Genetische Marker zum Testen des Risikos der Entwicklung einer Schizophrenie
|
EP3530672A1
(de)
|
2008-09-26 |
2019-08-28 |
Dana Farber Cancer Institute, Inc. |
Menschliche anti-pd1-, pd-l1- und pd-l2-antikörper und verwendungen davon
|
WO2010037224A1
(en)
|
2008-10-03 |
2010-04-08 |
St. Michael's Hospital |
Method for preventing and treating cardiovascular diseases with brca1
|
US20100120063A1
(en)
*
|
2008-10-10 |
2010-05-13 |
Discoverx Corporation |
GPCR Arrestin Assays
|
ES2548377T3
(es)
|
2008-10-27 |
2015-10-16 |
Revivicor, Inc. |
Ungulados inmunodeprimidos
|
WO2010053990A2
(en)
|
2008-11-04 |
2010-05-14 |
Janssen Pharmaceutica Nv |
Crhr2 peptide agonists and uses thereof
|
AU2009316541B2
(en)
|
2008-11-19 |
2015-08-06 |
Celularity Inc. |
Amnion derived adherent cells
|
EP2379720B1
(de)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Durch den promoter mir-21 angetriebene gezielte krebstherapie
|
WO2010088522A2
(en)
|
2009-01-30 |
2010-08-05 |
Ab Biosciences, Inc. |
Novel lowered affinity antibodies and uses therefor
|
US8211655B2
(en)
*
|
2009-02-12 |
2012-07-03 |
Discoverx Corporation |
Wild-type receptor assays
|
WO2011057027A2
(en)
|
2009-11-04 |
2011-05-12 |
Janssen Pharmaceutica Nv |
Method for treating heart failure with stresscopin-like peptides
|
WO2011060272A2
(en)
|
2009-11-13 |
2011-05-19 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
CN102770529B
(zh)
|
2009-11-17 |
2018-06-05 |
Musc研究发展基金会 |
针对人核仁素的人单克隆抗体
|
US9926593B2
(en)
|
2009-12-22 |
2018-03-27 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
EP3284818B1
(de)
|
2010-01-26 |
2022-03-09 |
Celularity Inc. |
Behandlung von knochenbedingten karzinomen mit plazentastammzellen
|
US9624290B2
(en)
|
2010-01-28 |
2017-04-18 |
Ab Biosciences, Inc. |
Lowered affinity antibodies and methods of making the same
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
WO2011120013A2
(en)
|
2010-03-26 |
2011-09-29 |
Trustees Of Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
KR20230054905A
(ko)
|
2010-04-07 |
2023-04-25 |
셀룰래리티 인코포레이티드 |
태반 줄기 세포를 사용한 혈관신생
|
JP5941040B2
(ja)
|
2010-05-13 |
2016-06-29 |
ザ ジェネラル ホスピタル コーポレイション |
副甲状腺ホルモン類似体およびその使用
|
ES2666746T3
(es)
|
2010-07-13 |
2018-05-07 |
Anthrogenesis Corporation |
Métodos para generar linfocitos citolíticos naturales
|
WO2012018387A2
(en)
|
2010-08-02 |
2012-02-09 |
Population Diagnotics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
RU2566267C2
(ru)
|
2010-09-14 |
2015-10-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ очистки пегилированного эритропоэтина
|
WO2012075337A2
(en)
|
2010-12-01 |
2012-06-07 |
Spinal Modulation, Inc. |
Directed delivery of agents to neural anatomy
|
EP2471543A1
(de)
|
2010-12-02 |
2012-07-04 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Toleranzinduktion oder Immunsuppression zur Verhinderung von insbesondere Transplantat-Wirt-Reaktion (GvHD) durch kurzzeitige Vorinkubation von transplantierten Zellsuspensionen, Geweben oder Organen, die mit Liganden zu Zelloberflächenmolekülen beschichtet sind
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
PL2714059T3
(pl)
|
2011-06-01 |
2019-04-30 |
Celularity Inc |
Leczenie bólu z użyciem komórek macierzystych łożyska
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
WO2013020044A1
(en)
|
2011-08-03 |
2013-02-07 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center |
Treatment of fibrosis using microrna-19b
|
CA2851388C
(en)
|
2011-10-10 |
2023-11-21 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
US11180807B2
(en)
|
2011-11-04 |
2021-11-23 |
Population Bio, Inc. |
Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
|
WO2013120018A1
(en)
|
2012-02-09 |
2013-08-15 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
CN108103069B
(zh)
|
2012-02-15 |
2021-08-10 |
诺和诺德股份有限公司 |
结合并阻断髓样细胞表达的触发受体-1 (trem-1)的抗体
|
PL2814842T3
(pl)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk A/S |
Przeciwciała wiążące białko 1 rozpoznające peptydoglikan
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
ES2930180T3
(es)
|
2012-03-02 |
2022-12-07 |
Sequenom Inc |
Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
|
WO2013152011A1
(en)
|
2012-04-02 |
2013-10-10 |
Ab Biosciences, Inc. |
Novel human control antibodies and uses therefor
|
EP3839050A3
(de)
*
|
2012-04-18 |
2021-09-29 |
The Board of Trustees of the Leland Stanford Junior University |
Disruptionsfreies gen-targeting
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
CN109793893B
(zh)
|
2012-09-07 |
2023-05-26 |
达特茅斯大学理事会 |
用于诊断和治疗癌症的vista调节剂
|
DK2895621T3
(da)
|
2012-09-14 |
2020-11-30 |
Population Bio Inc |
Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
|
CA2922005A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
CN103864913A
(zh)
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
US9763983B2
(en)
|
2013-02-05 |
2017-09-19 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
EP3597774A1
(de)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primer zur analyse der dna-methylierung
|
US10066001B2
(en)
|
2013-03-15 |
2018-09-04 |
Apotex Inc. |
Enhanced liquid formulation stability of erythropoietin alpha through purification processing
|
EP2968450A4
(de)
|
2013-03-15 |
2016-10-26 |
Angelica Therapeutics Inc |
Modifizierte toxine
|
US10294295B2
(en)
|
2013-11-27 |
2019-05-21 |
Inis Biotech Llc |
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CA2935378C
(en)
|
2013-12-24 |
2023-04-18 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
EP3736344A1
(de)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US10612041B2
(en)
|
2014-03-21 |
2020-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
GB2558326B
(en)
|
2014-09-05 |
2021-01-20 |
Population Bio Inc |
Methods and compositions for inhibiting and treating neurological conditions
|
KR102473092B1
(ko)
|
2014-09-15 |
2022-12-01 |
칠드런'즈 메디컬 센터 코포레이션 |
히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
|
EP3015475A1
(de)
|
2014-10-31 |
2016-05-04 |
Novartis AG |
Säugetierzellen zur Expression von Cytomegalovirus-Antigenen
|
JP2018505911A
(ja)
|
2014-12-05 |
2018-03-01 |
イミュネクスト,インコーポレーテッド |
推定上のvista受容体としてのvsig8の同定と、vista/vsig8調節剤を産生するためのその使用
|
EP3031822A1
(de)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus-Antigene
|
CA2973878A1
(en)
|
2015-01-22 |
2016-07-28 |
University Of Massachusetts |
Cancer immunotherapy
|
EP3048114A1
(de)
|
2015-01-22 |
2016-07-27 |
Novartis AG |
Cytomegalovirus-Antigene und Verwendungen davon
|
EP3047856A1
(de)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv-antigene und ihre verwendungen
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
CN109071669A
(zh)
|
2016-03-07 |
2018-12-21 |
查尔斯顿制药有限责任公司 |
抗核仁素抗体
|
SG11201808633RA
(en)
|
2016-04-15 |
2018-10-30 |
Immunext Inc |
Anti-human vista antibodies and use thereof
|
JP7177035B2
(ja)
|
2016-07-15 |
2022-11-22 |
エフ.ホフマン-ラ ロシュ アーゲー |
Peg化エリスロポエチンを精製するための方法
|
US10766798B2
(en)
*
|
2017-02-02 |
2020-09-08 |
Massachusetts Institute Of Technology |
Engineered yeast as a method for bioremediation
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
JP7410860B2
(ja)
|
2017-12-29 |
2024-01-10 |
エフ. ホフマン-ラ ロシュ アーゲー |
Peg化タンパク質組成物を提供するための方法
|
CN111727063A
(zh)
|
2017-12-29 |
2020-09-29 |
豪夫迈·罗氏有限公司 |
用于提供聚乙二醇化蛋白质组合物的方法
|
KR102523239B1
(ko)
|
2017-12-29 |
2023-04-18 |
에프. 호프만-라 로슈 아게 |
페길화 단백질 조성물을 제공하기 위한 방법
|
SI3625368T1
(sl)
|
2018-08-08 |
2023-04-28 |
Pml Screening, Llc |
Postopki z genetskim testiranjem za oceno tveganja za razvoj progresivne multifokalne levkoencefalopatije, ki jo povzroča virus John Cunningham
|
EP4004018A1
(de)
|
2019-07-24 |
2022-06-01 |
GlaxoSmithKline Biologicals SA |
Modifizierte humane cytomegalovirus-proteine
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|